HÜLYA DİROL, ÖMER ÖZBUDAK
Turkish Journal of Oncology - 2019;34(4):302-306
Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm. So in any organ, IMT has the potential of development. The most common sites that it arises are the lungs. It can occur in any age, but predominantly in children and adolescents. The etiology is not known. It is poorly understood on genetic and molecular level either. Clinical symptoms and radiological features are nonspecific in pulmonary IMT, can imitate lung cancer or tuberculosis. Diagnosis is based on histopathologic or immunohistochemical evaluation. The biological behavior is highly unpredictable, rarely metastase, frequently re-occure. Therapeutic approach rely mainly on complete surgical resection although there is no guideline for the treatment or follow-up. Here in, we report a pulmonary IMT case with clinical, radiological, histopathological features, and 2 year follow up results after complete surgical resection.
